Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Day One Biopharmaceuticals Inc increased its cash reserves by 170.68%, or 145.52m. Cash Flow from Financing totalled 164.00m or -- of revenues. In addition the company used 146.85m for operations while cash from investing totalled 128.38m.
Cash flow per share | -0.9344 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.51 |
---|---|
Tangible book value per share | 5.35 |
More ▼
Balance sheet in USDView more
Current ratio | 14.62 |
---|---|
Quick ratio | 14.55 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼